TORONTO, Dec 17, (LifeSiteNews.com) – Roberts Pharmaceuticals which recently commenced its exclusive marketing of the abortifacient “emergency contraceptive” Preven in Canada has deceived its investors in a letter issued today regarding the companies new abortifacient venture.
The company makes no mention of the abortifacient nature of the drugs and even fails to indicate that the drugs effect the lining of the endometrium (information which is contained in the drug’s promotional material).
Investors are told in the letter that “The pills in the PREVEN Emergency Contraceptive Kit work the same way birth control pills do, preventing a pregnancy from occurring by utilizing special doses of regular birth control pills.”
Pro-life observers note that pro-life investors in the company would be deceived by such wording into thinking that there exists no controversy over the abortifacient nature of the drugs.
Interestingly however, the company does list a long list of side effects of the drugs. “Only 1.9% of women became pregnant with this method compared to 7.2% with no contraception. The most common side effects are nausea and vomiting, but patients can experience irregular bleeding, breast tenderness, headache, abdominal pain/cramps, and dizziness. More serious side effects, such as blood clots, stroke, and heart attacks can occur.”